

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle contraction (GO:0003009) | 9.67998763 |
| 2 | regulation of skeletal muscle contraction (GO:0014819) | 9.42627625 |
| 3 | regulation of relaxation of muscle (GO:1901077) | 8.38609678 |
| 4 | myofibril assembly (GO:0030239) | 7.79663256 |
| 5 | striated muscle contraction (GO:0006941) | 7.65778812 |
| 6 | actin filament-based movement (GO:0030048) | 7.64265308 |
| 7 | sarcomere organization (GO:0045214) | 7.62810358 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.41235656 |
| 9 | creatine metabolic process (GO:0006600) | 7.11872882 |
| 10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.98695642 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.91337013 |
| 12 | response to muscle activity (GO:0014850) | 6.78111986 |
| 13 | cardiac myofibril assembly (GO:0055003) | 6.37713055 |
| 14 | response to inactivity (GO:0014854) | 6.30463724 |
| 15 | skeletal muscle fiber development (GO:0048741) | 6.13653339 |
| 16 | cardiac muscle contraction (GO:0060048) | 6.11498105 |
| 17 | muscle contraction (GO:0006936) | 5.77389729 |
| 18 | skeletal muscle adaptation (GO:0043501) | 5.69795919 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 5.64576468 |
| 20 | actomyosin structure organization (GO:0031032) | 5.64277653 |
| 21 | myotube cell development (GO:0014904) | 5.62683701 |
| 22 | regulation of cell communication by electrical coupling (GO:0010649) | 5.51846454 |
| 23 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.47789036 |
| 24 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.32864839 |
| 25 | glycogen catabolic process (GO:0005980) | 5.27538804 |
| 26 | cardiac muscle hypertrophy (GO:0003300) | 5.22106953 |
| 27 | plasma membrane repair (GO:0001778) | 5.19699888 |
| 28 | NADH metabolic process (GO:0006734) | 5.18823683 |
| 29 | muscle system process (GO:0003012) | 5.16467169 |
| 30 | striated muscle hypertrophy (GO:0014897) | 4.97472517 |
| 31 | glucan catabolic process (GO:0009251) | 4.95764552 |
| 32 | muscle fiber development (GO:0048747) | 4.85339400 |
| 33 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.77244352 |
| 34 | glucan biosynthetic process (GO:0009250) | 4.75161103 |
| 35 | glycogen biosynthetic process (GO:0005978) | 4.75161103 |
| 36 | cellular polysaccharide catabolic process (GO:0044247) | 4.65141082 |
| 37 | skeletal muscle tissue development (GO:0007519) | 4.61340787 |
| 38 | striated muscle adaptation (GO:0014888) | 4.58960176 |
| 39 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.49214913 |
| 40 | muscle hypertrophy (GO:0014896) | 4.44148374 |
| 41 | muscle tissue morphogenesis (GO:0060415) | 4.40693162 |
| 42 | adult heart development (GO:0007512) | 4.33985005 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 4.33792753 |
| 44 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.33507274 |
| 45 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.31399545 |
| 46 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.24612910 |
| 47 | polysaccharide catabolic process (GO:0000272) | 4.18757636 |
| 48 | 2-oxoglutarate metabolic process (GO:0006103) | 4.17162312 |
| 49 | skeletal muscle tissue regeneration (GO:0043403) | 4.16912293 |
| 50 | muscle cell cellular homeostasis (GO:0046716) | 4.15587952 |
| 51 | carnitine shuttle (GO:0006853) | 4.10341323 |
| 52 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.09166052 |
| 53 | cardiac muscle cell development (GO:0055013) | 4.06921722 |
| 54 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.98463990 |
| 55 | striated muscle cell development (GO:0055002) | 3.96962963 |
| 56 | tricarboxylic acid cycle (GO:0006099) | 3.91816299 |
| 57 | regulation of the force of heart contraction (GO:0002026) | 3.91586193 |
| 58 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.84969894 |
| 59 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.84969894 |
| 60 | glycogen metabolic process (GO:0005977) | 3.82863119 |
| 61 | muscle structure development (GO:0061061) | 3.77292115 |
| 62 | cardiac cell development (GO:0055006) | 3.77235069 |
| 63 | muscle organ development (GO:0007517) | 3.76272218 |
| 64 | fructose metabolic process (GO:0006000) | 3.76207554 |
| 65 | glucan metabolic process (GO:0044042) | 3.75212534 |
| 66 | cellular glucan metabolic process (GO:0006073) | 3.75212534 |
| 67 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.72739144 |
| 68 | muscle hypertrophy in response to stress (GO:0003299) | 3.72739144 |
| 69 | cardiac muscle adaptation (GO:0014887) | 3.72739144 |
| 70 | positive regulation of myotube differentiation (GO:0010831) | 3.72025321 |
| 71 | striated muscle atrophy (GO:0014891) | 3.71932810 |
| 72 | muscle cell fate commitment (GO:0042693) | 3.71069430 |
| 73 | muscle adaptation (GO:0043500) | 3.70392736 |
| 74 | muscle organ morphogenesis (GO:0048644) | 3.68403377 |
| 75 | gluconeogenesis (GO:0006094) | 3.67539308 |
| 76 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.65064615 |
| 77 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.65064615 |
| 78 | response to activity (GO:0014823) | 3.64773949 |
| 79 | heart process (GO:0003015) | 3.64761834 |
| 80 | heart contraction (GO:0060047) | 3.64761834 |
| 81 | fatty acid transmembrane transport (GO:1902001) | 3.47865840 |
| 82 | regulation of membrane repolarization (GO:0060306) | 3.45106132 |
| 83 | regulation of sequestering of triglyceride (GO:0010889) | 3.40966286 |
| 84 | muscle cell development (GO:0055001) | 3.40564729 |
| 85 | positive regulation of cation channel activity (GO:2001259) | 3.39359507 |
| 86 | muscle atrophy (GO:0014889) | 3.35107191 |
| 87 | relaxation of muscle (GO:0090075) | 3.34930978 |
| 88 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.32515766 |
| 89 | myoblast fusion (GO:0007520) | 3.31921432 |
| 90 | regulation of muscle system process (GO:0090257) | 3.29492561 |
| 91 | hexose biosynthetic process (GO:0019319) | 3.26905211 |
| 92 | striated muscle tissue development (GO:0014706) | 3.26597333 |
| 93 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.25553743 |
| 94 | regulation of myoblast differentiation (GO:0045661) | 3.25066410 |
| 95 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.20586977 |
| 96 | regulation of muscle contraction (GO:0006937) | 3.19389642 |
| 97 | actin-myosin filament sliding (GO:0033275) | 12.5581297 |
| 98 | muscle filament sliding (GO:0030049) | 12.5581297 |
| 99 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.1518061 |
| 100 | actin-mediated cell contraction (GO:0070252) | 10.3245347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.67453141 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.24924890 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.31880688 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.09421458 |
| 5 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.50091641 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.15732431 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.15732431 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.91559939 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.86240522 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.84915686 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.79130000 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.62197496 |
| 13 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.50577204 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41677318 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.34049794 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.32603854 |
| 17 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.21041785 |
| 18 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.10349965 |
| 19 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.90876403 |
| 20 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.78021066 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68470554 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.55453862 |
| 23 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.44704822 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39994546 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39442226 |
| 26 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.37986795 |
| 27 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36964830 |
| 28 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.33489563 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33226987 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29649178 |
| 31 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28102388 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26750027 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26454410 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22592336 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20992183 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.13822634 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11388922 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.11335795 |
| 39 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.10886555 |
| 40 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.07540061 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07209050 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05731062 |
| 43 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05563183 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04261293 |
| 45 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03790752 |
| 46 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02964911 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02627401 |
| 48 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02342385 |
| 49 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.01918845 |
| 50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00926725 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00051735 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97467388 |
| 53 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96568519 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96026638 |
| 55 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93714106 |
| 56 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.93656978 |
| 57 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92238567 |
| 58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92101298 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91993332 |
| 60 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91640970 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91321050 |
| 62 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91065096 |
| 63 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91031641 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90268486 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90202559 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89914166 |
| 67 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89570097 |
| 68 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89128700 |
| 69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.85678976 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83752020 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83752020 |
| 72 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83138078 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.82867940 |
| 74 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.82857264 |
| 75 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80953131 |
| 76 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78717008 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78704454 |
| 78 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78660023 |
| 79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.76982672 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.76844592 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.76007935 |
| 82 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.75840409 |
| 83 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72414283 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.72023720 |
| 85 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71526569 |
| 86 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.69524866 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69512854 |
| 88 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.69494430 |
| 89 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.69494430 |
| 90 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.69273453 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68980167 |
| 92 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.68918624 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.68903320 |
| 94 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.68416476 |
| 95 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.68069238 |
| 96 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.67951637 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.67457306 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67066183 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65976405 |
| 100 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.65686902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.96705109 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 6.55475699 |
| 3 | MP0000751_myopathy | 6.17696716 |
| 4 | MP0000749_muscle_degeneration | 5.69398377 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.49450859 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.71259205 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.61252962 |
| 8 | MP0004087_abnormal_muscle_fiber | 3.49987915 |
| 9 | MP0000747_muscle_weakness | 3.46145223 |
| 10 | MP0000759_abnormal_skeletal_muscle | 3.34638187 |
| 11 | MP0005451_abnormal_body_composition | 3.15489966 |
| 12 | MP0005369_muscle_phenotype | 3.13324724 |
| 13 | MP0002269_muscular_atrophy | 3.01980473 |
| 14 | MP0002332_abnormal_exercise_endurance | 3.00719106 |
| 15 | MP0004130_abnormal_muscle_cell | 2.96152507 |
| 16 | MP0005330_cardiomyopathy | 2.90779750 |
| 17 | MP0005620_abnormal_muscle_contractility | 2.90547068 |
| 18 | MP0000750_abnormal_muscle_regeneration | 2.87444930 |
| 19 | MP0004233_abnormal_muscle_weight | 2.85804338 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.62793626 |
| 21 | MP0002972_abnormal_cardiac_muscle | 2.35552760 |
| 22 | MP0004215_abnormal_myocardial_fiber | 2.28420647 |
| 23 | MP0000733_abnormal_muscle_development | 2.01220869 |
| 24 | MP0004484_altered_response_of | 1.98235330 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.91106598 |
| 26 | MP0002108_abnormal_muscle_morphology | 1.90096968 |
| 27 | MP0004510_myositis | 1.80844019 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.74341377 |
| 29 | MP0006138_congestive_heart_failure | 1.63370376 |
| 30 | MP0002127_abnormal_cardiovascular_syste | 1.59991246 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.59806792 |
| 32 | MP0001544_abnormal_cardiovascular_syste | 1.59806792 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.52768504 |
| 34 | MP0005266_abnormal_metabolism | 1.40269557 |
| 35 | MP0004270_analgesia | 1.37322955 |
| 36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30132284 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.22430916 |
| 38 | MP0003137_abnormal_impulse_conducting | 1.21907209 |
| 39 | MP0005670_abnormal_white_adipose | 1.16533814 |
| 40 | MP0001661_extended_life_span | 1.10384366 |
| 41 | MP0002971_abnormal_brown_adipose | 1.09704655 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.05051199 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 0.96309909 |
| 44 | MP0005666_abnormal_adipose_tissue | 0.94313205 |
| 45 | MP0004085_abnormal_heartbeat | 0.91888952 |
| 46 | MP0005375_adipose_tissue_phenotype | 0.89942345 |
| 47 | MP0002822_catalepsy | 0.83140523 |
| 48 | MP0000003_abnormal_adipose_tissue | 0.80635485 |
| 49 | MP0003828_pulmonary_edema | 0.78959078 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 0.75385227 |
| 51 | MP0003045_fibrosis | 0.72440391 |
| 52 | MP0000372_irregular_coat_pigmentation | 0.71394814 |
| 53 | MP0000266_abnormal_heart_morphology | 0.68806143 |
| 54 | MP0004147_increased_porphyrin_level | 0.65756592 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 0.57618318 |
| 56 | MP0003879_abnormal_hair_cell | 0.55880475 |
| 57 | MP0001299_abnormal_eye_distance/ | 0.55379728 |
| 58 | MP0004134_abnormal_chest_morphology | 0.53216104 |
| 59 | MP0004043_abnormal_pH_regulation | 0.50710760 |
| 60 | MP0002078_abnormal_glucose_homeostasis | 0.50091526 |
| 61 | MP0005165_increased_susceptibility_to | 0.49050744 |
| 62 | MP0002638_abnormal_pupillary_reflex | 0.44897205 |
| 63 | MP0008569_lethality_at_weaning | 0.44018815 |
| 64 | MP0002128_abnormal_blood_circulation | 0.43554133 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 0.41201938 |
| 66 | MP0004142_abnormal_muscle_tone | 0.38823873 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.37066224 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.36968179 |
| 69 | MP0009672_abnormal_birth_weight | 0.34616436 |
| 70 | MP0005535_abnormal_body_temperature | 0.34476938 |
| 71 | MP0005452_abnormal_adipose_tissue | 0.31929411 |
| 72 | MP0000230_abnormal_systemic_arterial | 0.30930558 |
| 73 | MP0005083_abnormal_biliary_tract | 0.30530770 |
| 74 | MP0003948_abnormal_gas_homeostasis | 0.30520315 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 0.30435404 |
| 76 | MP0005334_abnormal_fat_pad | 0.29793088 |
| 77 | MP0000762_abnormal_tongue_morphology | 0.29779866 |
| 78 | MP0002114_abnormal_axial_skeleton | 0.29291179 |
| 79 | MP0005423_abnormal_somatic_nervous | 0.29039082 |
| 80 | MP0005166_decreased_susceptibility_to | 0.28497553 |
| 81 | MP0010030_abnormal_orbit_morphology | 0.28135178 |
| 82 | MP0005332_abnormal_amino_acid | 0.26914973 |
| 83 | MP0005187_abnormal_penis_morphology | 0.26831337 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.25851344 |
| 85 | MP0001346_abnormal_lacrimal_gland | 0.25666313 |
| 86 | MP0009250_abnormal_appendicular_skeleto | 0.25109845 |
| 87 | MP0002734_abnormal_mechanical_nocicepti | 0.24573121 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.23907150 |
| 89 | MP0002066_abnormal_motor_capabilities/c | 0.21105728 |
| 90 | MP0001943_abnormal_respiration | 0.20320436 |
| 91 | MP0006276_abnormal_autonomic_nervous | 0.19205631 |
| 92 | MP0004924_abnormal_behavior | 0.16721900 |
| 93 | MP0005386_behavior/neurological_phenoty | 0.16721900 |
| 94 | MP0009115_abnormal_fat_cell | 0.15514075 |
| 95 | MP0002067_abnormal_sensory_capabilities | 0.13861928 |
| 96 | MP0000343_altered_response_to | 0.13694678 |
| 97 | MP0003959_abnormal_lean_body | 0.13266508 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.12222986 |
| 99 | MP0001984_abnormal_olfaction | 0.11857653 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.11565039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 8.31178456 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.97847271 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.47898640 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.39917010 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 5.82485417 |
| 6 | Distal arthrogryposis (HP:0005684) | 5.62615562 |
| 7 | Myopathic facies (HP:0002058) | 5.62581797 |
| 8 | EMG: myopathic abnormalities (HP:0003458) | 5.48853885 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.09427268 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 4.98946356 |
| 11 | Rhabdomyolysis (HP:0003201) | 4.91693852 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 4.88401109 |
| 13 | Myoglobinuria (HP:0002913) | 4.87785024 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.71678673 |
| 15 | Round ear (HP:0100830) | 4.60690561 |
| 16 | Neck muscle weakness (HP:0000467) | 4.54854397 |
| 17 | Rimmed vacuoles (HP:0003805) | 4.45984403 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.40008379 |
| 19 | Subaortic stenosis (HP:0001682) | 4.40008379 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 4.28940283 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.26300412 |
| 22 | Sudden death (HP:0001699) | 4.04855802 |
| 23 | Difficulty running (HP:0009046) | 4.03598609 |
| 24 | Increased connective tissue (HP:0009025) | 3.81228189 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 3.80197866 |
| 26 | Calcaneovalgus deformity (HP:0001848) | 3.76384484 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 3.70352571 |
| 28 | Bundle branch block (HP:0011710) | 3.67033362 |
| 29 | Muscle stiffness (HP:0003552) | 3.61128819 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.54735777 |
| 31 | Frequent falls (HP:0002359) | 3.48921648 |
| 32 | Absent phalangeal crease (HP:0006109) | 3.43222970 |
| 33 | Areflexia of lower limbs (HP:0002522) | 3.40405413 |
| 34 | Deformed tarsal bones (HP:0008119) | 3.33906809 |
| 35 | Myotonia (HP:0002486) | 3.30214155 |
| 36 | EMG: neuropathic changes (HP:0003445) | 3.28057200 |
| 37 | Malignant hyperthermia (HP:0002047) | 3.02598851 |
| 38 | Generalized muscle weakness (HP:0003324) | 2.96016154 |
| 39 | Ventricular tachycardia (HP:0004756) | 2.95139724 |
| 40 | Abnormal finger flexion creases (HP:0006143) | 2.83983279 |
| 41 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.82534248 |
| 42 | Dilated cardiomyopathy (HP:0001644) | 2.81441258 |
| 43 | Lipoatrophy (HP:0100578) | 2.61582962 |
| 44 | Distal lower limb amyotrophy (HP:0008944) | 2.59148324 |
| 45 | Bulbar palsy (HP:0001283) | 2.56345388 |
| 46 | Slender build (HP:0001533) | 2.47777893 |
| 47 | Scapular winging (HP:0003691) | 2.43061524 |
| 48 | Weak cry (HP:0001612) | 2.40601205 |
| 49 | Fetal akinesia sequence (HP:0001989) | 2.37483742 |
| 50 | Progressive muscle weakness (HP:0003323) | 2.35799521 |
| 51 | Limb-girdle muscle atrophy (HP:0003797) | 2.35753679 |
| 52 | Gowers sign (HP:0003391) | 2.34581703 |
| 53 | Heart block (HP:0012722) | 2.31906189 |
| 54 | Hyperkalemia (HP:0002153) | 2.31245579 |
| 55 | Fatigable weakness (HP:0003473) | 2.21852562 |
| 56 | Abnormality of the neuromuscular junction (HP:0003398) | 2.21852562 |
| 57 | Spinal rigidity (HP:0003306) | 2.19744523 |
| 58 | Muscular dystrophy (HP:0003560) | 2.19724373 |
| 59 | Abnormality of the foot musculature (HP:0001436) | 2.18041847 |
| 60 | Abnormal atrioventricular conduction (HP:0005150) | 2.17113538 |
| 61 | Proximal amyotrophy (HP:0007126) | 2.13677678 |
| 62 | Abnormality of the calcaneus (HP:0008364) | 2.12850298 |
| 63 | Hip contracture (HP:0003273) | 2.12174236 |
| 64 | Difficulty climbing stairs (HP:0003551) | 2.11213342 |
| 65 | Ragged-red muscle fibers (HP:0003200) | 2.05695031 |
| 66 | Waddling gait (HP:0002515) | 2.04611377 |
| 67 | Ventricular arrhythmia (HP:0004308) | 2.01436479 |
| 68 | Nemaline bodies (HP:0003798) | 10.9225762 |
| 69 | Muscle fiber inclusion bodies (HP:0100299) | 10.9221280 |
| 70 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.5842161 |
| 71 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.99030606 |
| 72 | Foot dorsiflexor weakness (HP:0009027) | 1.96687510 |
| 73 | Lower limb amyotrophy (HP:0007210) | 1.96304325 |
| 74 | Exercise intolerance (HP:0003546) | 1.84121534 |
| 75 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82347841 |
| 76 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.78651801 |
| 77 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.78651801 |
| 78 | Shoulder girdle muscle weakness (HP:0003547) | 1.71669192 |
| 79 | Pelvic girdle muscle weakness (HP:0003749) | 1.70896697 |
| 80 | Limb-girdle muscle weakness (HP:0003325) | 1.70349359 |
| 81 | Long clavicles (HP:0000890) | 1.68548280 |
| 82 | Facial diplegia (HP:0001349) | 1.66054167 |
| 83 | Paralysis (HP:0003470) | 1.65255542 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 1.63989250 |
| 85 | Atrial fibrillation (HP:0005110) | 1.62658469 |
| 86 | Nonprogressive disorder (HP:0003680) | 1.59778431 |
| 87 | Increased muscle lipid content (HP:0009058) | 1.53033383 |
| 88 | Ventricular fibrillation (HP:0001663) | 1.51209160 |
| 89 | Popliteal pterygium (HP:0009756) | 1.48853292 |
| 90 | Steppage gait (HP:0003376) | 1.48018256 |
| 91 | Syncope (HP:0001279) | 1.47797850 |
| 92 | Primary atrial arrhythmia (HP:0001692) | 1.47371712 |
| 93 | Atrioventricular block (HP:0001678) | 1.46991948 |
| 94 | Palpitations (HP:0001962) | 1.46535525 |
| 95 | Type 2 muscle fiber atrophy (HP:0003554) | 1.45726319 |
| 96 | Metatarsus adductus (HP:0001840) | 1.45489289 |
| 97 | Ulnar deviation of finger (HP:0009465) | 1.44917674 |
| 98 | Oligomenorrhea (HP:0000876) | 1.43292576 |
| 99 | Supraventricular tachycardia (HP:0004755) | 1.42303341 |
| 100 | Limited hip movement (HP:0008800) | 1.42075319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.44010909 |
| 2 | PHKG2 | 5.96178279 |
| 3 | PHKG1 | 5.96178279 |
| 4 | PIK3CG | 2.74070009 |
| 5 | PINK1 | 2.02282432 |
| 6 | OBSCN | 10.9470161 |
| 7 | MAPK12 | 1.96622783 |
| 8 | MUSK | 1.75039177 |
| 9 | MAP3K7 | 1.70771751 |
| 10 | MAP2K3 | 1.68462875 |
| 11 | DMPK | 1.29259589 |
| 12 | MAPKAPK3 | 1.28314913 |
| 13 | TRPM7 | 1.22561489 |
| 14 | MARK1 | 1.20566234 |
| 15 | MAP2K4 | 1.12801405 |
| 16 | NEK1 | 1.06290535 |
| 17 | NME1 | 1.06259650 |
| 18 | LIMK1 | 0.98404879 |
| 19 | EEF2K | 0.96856876 |
| 20 | PRKAA2 | 0.91294394 |
| 21 | CAMK2G | 0.89840191 |
| 22 | CCNB1 | 0.86489625 |
| 23 | PDK2 | 0.84325787 |
| 24 | MOS | 0.79779925 |
| 25 | MAP2K6 | 0.78403100 |
| 26 | PRKAA1 | 0.77362189 |
| 27 | ERBB3 | 0.74421354 |
| 28 | CAMK4 | 0.69972013 |
| 29 | NEK9 | 0.69700718 |
| 30 | DYRK1B | 0.66494992 |
| 31 | MAPK7 | 0.66280147 |
| 32 | CAMK2D | 0.66255222 |
| 33 | BCKDK | 0.62573337 |
| 34 | AKT2 | 0.60194123 |
| 35 | PIK3CA | 0.57205855 |
| 36 | RIPK1 | 0.55518982 |
| 37 | PKN1 | 0.55146342 |
| 38 | PRKG1 | 0.53687487 |
| 39 | MAPK4 | 0.51587135 |
| 40 | CAMK1 | 0.50856942 |
| 41 | CAMK2A | 0.50175398 |
| 42 | MAPK11 | 0.49516902 |
| 43 | MAP3K13 | 0.48936659 |
| 44 | ROCK1 | 0.47662420 |
| 45 | MAP2K1 | 0.47514170 |
| 46 | MYLK | 0.46180336 |
| 47 | CAMK2B | 0.45935920 |
| 48 | KSR2 | 0.44567818 |
| 49 | TRIB3 | 0.43805949 |
| 50 | TIE1 | 0.42709734 |
| 51 | SGK3 | 0.42547681 |
| 52 | ICK | 0.39331151 |
| 53 | PRKACA | 0.35476573 |
| 54 | SGK2 | 0.32396163 |
| 55 | LATS2 | 0.30695460 |
| 56 | RPS6KA3 | 0.28191535 |
| 57 | PRKD1 | 0.27304189 |
| 58 | TBK1 | 0.25477968 |
| 59 | PRKACB | 0.24593261 |
| 60 | SGK1 | 0.24519089 |
| 61 | MAPK13 | 0.23548555 |
| 62 | RPS6KB1 | 0.23164532 |
| 63 | RPS6KC1 | 0.22690017 |
| 64 | RPS6KL1 | 0.22690017 |
| 65 | MAPK10 | 0.22656997 |
| 66 | RPS6KA1 | 0.22033922 |
| 67 | MAP3K1 | 0.20236792 |
| 68 | PRKACG | 0.19325246 |
| 69 | RPS6KA6 | 0.18557278 |
| 70 | LATS1 | 0.18213875 |
| 71 | PDPK1 | 0.17696796 |
| 72 | TAOK2 | 0.16714586 |
| 73 | MARK2 | 0.16653858 |
| 74 | MAP3K6 | 0.16051466 |
| 75 | DAPK2 | 0.15550862 |
| 76 | RPS6KB2 | 0.15107273 |
| 77 | MARK3 | 0.14064714 |
| 78 | EPHA3 | 0.14059902 |
| 79 | EPHB1 | 0.13823370 |
| 80 | PDK1 | 0.12696245 |
| 81 | GRK7 | 0.12512178 |
| 82 | SGK223 | 0.12500238 |
| 83 | SGK494 | 0.12500238 |
| 84 | MTOR | 0.12397013 |
| 85 | PAK3 | 0.12200206 |
| 86 | PRPF4B | 0.11698981 |
| 87 | STK11 | 0.11404512 |
| 88 | SIK1 | 0.11295203 |
| 89 | ZAP70 | 0.08881411 |
| 90 | TGFBR2 | 0.08493363 |
| 91 | CDC42BPA | 0.07902195 |
| 92 | RAF1 | 0.07721995 |
| 93 | MAP3K10 | 0.04987952 |
| 94 | KSR1 | 0.04766957 |
| 95 | NLK | 0.04756642 |
| 96 | MAPK9 | 0.04450967 |
| 97 | ARAF | 0.03991936 |
| 98 | MAP3K5 | 0.03571393 |
| 99 | ROCK2 | 0.02885475 |
| 100 | GSK3B | 0.02880083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.71315297 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.33374306 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.31084592 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.18470216 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.99139061 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.59605540 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.29077205 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.56817496 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.30619757 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.20315557 |
| 11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.14574953 |
| 12 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.99599560 |
| 13 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.94345765 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82912680 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.81040994 |
| 16 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75034374 |
| 17 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.73069053 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70492997 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68250120 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.61882270 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.59339625 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.59160802 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58468222 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.56823054 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.52679184 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49059478 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.43719975 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41330268 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.26449159 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23861529 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21621302 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.19486997 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19324725 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17945763 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15217657 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15033944 |
| 37 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08280687 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05424934 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.04953638 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.96653080 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95232161 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.93081752 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 0.91095131 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82978561 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 0.79618377 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74387116 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72983477 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67452824 |
| 49 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67242622 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66186606 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 0.65902071 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63758724 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61110605 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56686991 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55989874 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52315364 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52265205 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52031209 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.51883830 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50815673 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49518636 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49299927 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47299935 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45526227 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.42192653 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38969751 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37648519 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.36599247 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35678793 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35608113 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.35385362 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.33853304 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32294759 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30618978 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.30569467 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29692380 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26574773 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25688941 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25346981 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24266981 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24134080 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.22197365 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.22165357 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.22025546 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18993364 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18721873 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.18424572 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15363728 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.14977013 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14907592 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.14578185 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.13858943 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.12550551 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.12087994 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.10918041 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.10455348 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.10385503 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.08218180 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08166354 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07806467 |

